M21 Are there any differences in cancer outcomes according to time between baseline chest X-ray and lung cancer diagnosis?

Author(s):  
R Aslam ◽  
MPT Kennedy ◽  
B Bhartia ◽  
B Shinkins ◽  
RD Neal ◽  
...  
2010 ◽  
Vol 28 (20) ◽  
pp. 3307-3315 ◽  
Author(s):  
Hardeep Singh ◽  
Kamal Hirani ◽  
Himabindu Kadiyala ◽  
Olga Rudomiotov ◽  
Traber Davis ◽  
...  

Purpose Understanding delays in cancer diagnosis requires detailed information about timely recognition and follow-up of signs and symptoms. This information has been difficult to ascertain from paper-based records. We used an integrated electronic health record (EHR) to identify characteristics and predictors of missed opportunities for earlier diagnosis of lung cancer. Methods Using a retrospective cohort design, we evaluated 587 patients of primary lung cancer at two tertiary care facilities. Two physicians independently reviewed each case, and disagreements were resolved by consensus. Type I missed opportunities were defined as failure to recognize predefined clinical clues (ie, no documented follow-up) within 7 days. Type II missed opportunities were defined as failure to complete a requested follow-up action within 30 days. Results Reviewers identified missed opportunities in 222 (37.8%) of 587 patients. Median time to diagnosis in cases with and without missed opportunities was 132 days and 19 days, respectively (P < .001). Abnormal chest x-ray was the clue most frequently associated with type I missed opportunities (62%). Follow-up on abnormal chest x-ray (odds ratio [OR], 2.07; 95% CI, 1.04 to 4.13) and completion of first needle biopsy (OR, 3.02; 95% CI, 1.76 to 5.18) were associated with type II missed opportunities. Patient adherence contributed to 44% of patients with missed opportunities. Conclusion Preventable delays in lung cancer diagnosis arose mostly from failure to recognize documented abnormal imaging results and failure to complete key diagnostic procedures in a timely manner. Potential solutions include EHR-based strategies to improve recognition of abnormal imaging and track patients with suspected cancers.


2020 ◽  
pp. bjgp20X714077
Author(s):  
Kirsten Deanne Arendse ◽  
Fiona M. Walter ◽  
Mark Pilling ◽  
Yin Zhou ◽  
William Hamilton ◽  
...  

Abstract Background: National guidelines in England recommend prompt chest X-ray (within 14-days) in patients presenting in General Practice with unexplained symptoms of possible lung cancer, including persistent cough, shortness of breath or weight loss. Aim: To examine time to chest X-ray in symptomatic patients in English General Practice prior to lung cancer diagnosis and explore variation by demographics. Design and Setting: Retrospective cohort study using routinely collected General Practice, cancer registry and imaging data from England. Method: Patients with lung cancer who presented symptomatically in General Practice in the year pre-diagnosis and had a pre-diagnostic chest X-ray were included. Time from presentation to chest X-ray (presentation-test interval) was determined and intervals classified based on national guideline recommendations as concordant (≤14 days) or non-concordant (>14 days). Variation in intervals was examined by age, sex, smoking status and deprivation. Results: In a cohort of 2102 lung cancer patients, the median presentation-test interval was 49 days (interquartile range, IQR:5-172). 727 (35%) patients had presentation-test intervals of <14 days (median:1 day; IQR:0-6) and 1375 (65%) had presentation-test intervals of >14 days (median:128 days; IQR:52-231). Intervals were longer among smokers than non-smokers (63% longer; p<0.001), older patients (7% longer for every 10-years; p=0.013) and females (12% longer than males; p=0.016). Conclusion: In symptomatic primary care patients who underwent chest X-ray before lung cancer diagnosis, only 35% were tested within the timeframe recommended by national guidelines. Smokers, older patients and females experienced longer intervals. These findings could help guide initiatives aimed at improving timely lung cancer diagnosis.


Thorax ◽  
2018 ◽  
Vol 73 (12) ◽  
pp. 1128-1136 ◽  
Author(s):  
Martyn P T Kennedy ◽  
Leanne Cheyne ◽  
Michael Darby ◽  
Paul Plant ◽  
Richard Milton ◽  
...  

BackgroundLung cancer outcomes in the UK are worse than in many other developed nations. Symptom awareness campaigns aim to diagnose patients at an earlier stage to improve cancer outcomes.MethodsAn early diagnosis campaign for lung cancer commenced in Leeds, UK in 2011 comprising public and primary-care facing components. Rates of community referral for chest X-ray and lung cancer stage (TNM seventh edition) at presentation were collected from 2008 to 2015. Linear trends were assessed by χ2 test for trend in proportions. Headline figures are presented for the 3 years pre-campaign (2008–2010) and the three most recent years for which data are available during the campaign (2013–2015).FindingsCommunity-ordered chest X-ray rates per year increased from 18 909 in 2008–2010 to 34 194 in 2013–2015 (80.8% increase). A significant stage shift towards earlier stage lung cancer was seen (χ2(1)=32.2, p<0.0001). There was an 8.8 percentage point increase in the proportion of patients diagnosed with stage I/II lung cancer (26.5% pre-campaign vs 35.3% during campaign) and a 9.3% reduction in the absolute number of patients diagnosed with stage III/IV disease (1254 pre-campaign vs 1137 during campaign).InterpretationThis is the largest described lung cancer stage-shift in association with a symptom awareness campaign. A causal link between the campaign and stage-shift cannot be proven but appears plausible. Limitations of the analysis include a lack of contemporary control population.


2018 ◽  
Vol 30 (1) ◽  
pp. 90 ◽  
Author(s):  
Peng Zhang ◽  
Xinnan Xu ◽  
Hongwei Wang ◽  
Yuanli Feng ◽  
Haozhe Feng ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document